$AAPL
Apple Inc. Stock $aapl

$aapl Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-Q Financial Statement

#000119312512182321 Filed on April 25, 2012

Income Statement

Concept	2012 Q1	2011 Q1
Revenue	$39.19B	$24.67B
YoY Change	58.86%	82.73%
Cost Of Revenue	$20.62B	$14.45B
YoY Change	42.72%	83.5%
Gross Profit	$18.56B	$10.22B
YoY Change	81.68%	81.65%
Gross Profit Margin	47.37%	41.42%
Selling, General & Admin	$2.339B	$1.763B
YoY Change	32.67%	44.51%
% of Gross Profit	12.6%	17.25%
Research & Development	$841.0M	$581.0M
YoY Change	44.75%	36.38%
% of Gross Profit	4.53%	5.69%
Depreciation & Amortization	$740.0M	$434.0M
YoY Change	70.51%	100.93%
% of Gross Profit	3.99%	4.25%
Operating Expenses	$3.180B	$2.344B
YoY Change	35.67%	42.41%
Operating Profit	$15.38B	$7.874B
YoY Change	95.38%	97.89%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$148.0M	$26.00M
YoY Change	469.23%	-48.0%
Pretax Income	$15.53B	$7.900B
YoY Change	96.61%	96.08%
Income Tax	$3.910B	$1.913B
% Of Pretax Income	25.17%	24.22%
Net Earnings	$11.62B	$5.987B
YoY Change	94.12%	94.76%
Net Earnings / Revenue	29.66%	24.27%
Basic Earnings Per Share	$12.45	$6.49
Diluted Earnings Per Share	$12.30	$6.40
COMMON SHARES
Basic Shares Outstanding	933.6M shares	923.2M shares
Diluted Shares Outstanding	944.9M shares	935.9M shares

Balance Sheet

Concept	2012 Q1	2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.54B	$29.23B
YoY Change	-2.38%	26.25%
Cash & Equivalents	$10.12B	$15.98B
Short-Term Investments	$18.42B	$13.26B
Other Short-Term Assets	$5.050B	$5.738B
YoY Change	-11.99%	46.6%
Inventory	$1.102B	$930.0M
Prepaid Expenses
Receivables	$7.042B	$5.798B
Other Receivables	$6.727B	$5.297B
Total Short-Term Assets	$50.71B	$47.00B
YoY Change	7.9%	45.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.847B	$6.241B
YoY Change	41.76%	78.11%
Goodwill	$1.141B
YoY Change
Intangibles	$3.604B
YoY Change
Long-Term Investments	$81.64B	$36.53B
YoY Change	123.46%	96.95%
Other Assets	$4.992B	$3.885B
YoY Change	28.49%	110.57%
Total Long-Term Assets	$100.2B	$47.91B
YoY Change	109.2%	93.79%
TOTAL ASSETS
Total Short-Term Assets	$50.71B	$47.00B
Total Long-Term Assets	$100.2B	$47.91B
Total Assets	$150.9B	$94.90B
YoY Change	59.04%	66.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.01B	$13.71B
YoY Change	24.04%	142.04%
Accrued Expenses	$9.778B	$2.104B
YoY Change	364.73%	70.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$32.04B	$24.33B
YoY Change	31.69%	98.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$13.95B	$2.950B
YoY Change	373.02%	31.76%
Total Long-Term Liabilities	$13.95B	$2.950B
YoY Change	373.02%	31.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.04B	$24.33B
Total Long-Term Liabilities	$13.95B	$2.950B
Total Liabilities	$48.44B	$33.43B
YoY Change	44.9%	88.76%
SHAREHOLDERS EQUITY
Retained Earnings	$87.12B
YoY Change
Common Stock	$14.85B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$102.5B	$61.48B
YoY Change
Total Liabilities & Shareholders Equity	$150.9B	$94.90B
YoY Change	59.04%	66.33%

Cashflow Statement

Concept	2012 Q1	2011 Q1
OPERATING ACTIVITIES
Net Income	$11.62B	$5.987B
YoY Change	94.12%	94.76%
Depreciation, Depletion And Amortization	$740.0M	$434.0M
YoY Change	70.51%	100.93%
Cash From Operating Activities	$13.98B	$6.219B
YoY Change	124.75%	166.91%
INVESTING ACTIVITIES
Capital Expenditures	-$1.509B	-$656.0M
YoY Change	130.03%	117.94%
Acquisitions
YoY Change
Other Investing Activities	-$12.97B	-$866.0M
YoY Change	1397.34%	-497.25%
Cash From Investing Activities	-$14.48B	-$1.522B
YoY Change	851.12%	1733.73%
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	310.0M	547.0M
YoY Change	-43.33%	237.65%
NET CHANGE
Cash From Operating Activities	13.98B	6.219B
Cash From Investing Activities	-14.48B	-1.522B
Cash From Financing Activities	310.0M	547.0M
Net Change In Cash	-189.0M	5.244B
YoY Change	-103.6%	117.68%
FREE CASH FLOW
Cash From Operating Activities	$13.98B	$6.219B
Capital Expenditures	-$1.509B	-$656.0M
Free Cash Flow	$15.49B	$6.875B
YoY Change	125.25%	161.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q3	us-gaap	Goodwill Goodwill	896000000
CY2011Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	55618000000
CY2011Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11768000000
CY2011Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2014000000
CY2011Q3	us-gaap	Other Assets Current OtherAssetsCurrent	4529000000
CY2011Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1240000000
CY2011Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	53000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11866000	shares
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	130000000
CY2011Q3	us-gaap	Common Stock Value CommonStockValue	13331000000
CY2011Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6348000000
CY2011Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3556000000
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	76615000000
CY2011Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	81464000000
CY2011Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2011Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3641000000
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	23000000
CY2011Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1800000000	shares
CY2011Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590000000
CY2011Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	929277000	shares
CY2011Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	563000000
CY2011Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2011Q3	us-gaap	Liabilities Liabilities	39756000000
CY2011Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	14632000000
CY2011Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1400000000
CY2011Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	16137000000
CY2011Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4091000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	231.49
CY2011Q3	us-gaap	Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	9891000000
CY2011Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10100000000
CY2011Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62841000000
CY2011Q3	us-gaap	Assets Assets	116371000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	108.64
CY2011Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	8159000000
CY2011Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5369000000
CY2011Q3	us-gaap	Inventory Net InventoryNet	776000000
CY2011Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	264000000
CY2011Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116371000000
CY2011Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2599000000
CY2011Q3	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	2038000000
CY2011Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	598000000
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9815000000
CY2011Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	158000000
CY2011Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	929277000	shares
CY2011Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3536000000
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	443000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	14446000	shares
CY2011Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9247000000
CY2011Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	184000000
CY2011Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1941000000
CY2011Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27970000000
CY2011Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1686000000
CY2011Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1140000000
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	290000000
CY2011Q3	us-gaap	Assets Current AssetsCurrent	44988000000
CY2011Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3991000000
CY2011Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7777000000
CY2011Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	81570000000
CY2011Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	261000000
CY2011Q3	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	56000000
CY2011Q3	aapl	Land And Buildings Gross LandAndBuildingsGross	2059000000
CY2011Q3	aapl	Machinery Equipment And Internal Use Software Gross MachineryEquipmentAndInternalUseSoftwareGross	6926000000
CY2011Q3	aapl	Notional Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	13705000000
CY2011Q3	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	537000000
CY2011Q3	aapl	Prepaid Expense Other Current Noncurrent PrepaidExpenseOtherCurrentNoncurrent	2300000000
CY2011Q3	aapl	Collateral Already Received Aggregate Fair Value CollateralAlreadyReceivedAggregateFairValue	288000000
CY2011Q3	aapl	Number Of Significant Vendors NumberOfSignificantVendors	2	Vendor
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	935062000	shares
CY2010Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	904000000
CY2011Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1103000000
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15978000000
CY2011Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1676000000
CY2012Q1	us-gaap	Goodwill Goodwill	1141000000
CY2012Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	81638000000
CY2012Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13941000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	39100000	shares
CY2012Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2253000000
CY2012Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5050000000
CY2012Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1678000000
CY2012Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6727000000
CY2012Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4992000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8436000	shares
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	102498000000
CY2012Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	109752000000
CY2012Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4400000000
CY2012Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3943000000
CY2012Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4073404000
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	26000000
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1800000000	shares
CY2012Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	551000000
CY2012Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	653000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	116.67
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4170553000
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	934982000	shares
CY2012Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	705000000
CY2012Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	2400000000
CY2012Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q1	us-gaap	Liabilities Liabilities	48436000000
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	17011000000
CY2012Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1700000000
CY2012Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	18417000000
CY2012Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5247000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	307.88
CY2012Q1	us-gaap	Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	13585000000
CY2012Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13954000000
CY2012Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	87124000000
CY2012Q1	us-gaap	Assets Assets	150934000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	116.95
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	11704000000
CY2012Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7042000000
CY2012Q1	us-gaap	Inventory Net InventoryNet	1102000000
CY2012Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	500000000
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	150934000000
CY2012Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2930000000
CY2012Q1	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	1746000000
CY2012Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	561000000
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10121000000
CY2012Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	76000000
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	934982000	shares
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3604000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	206000	shares
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	524000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	16914000	shares
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9778000000
CY2012Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	210000000
CY2012Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2250000000
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32036000000
CY2012Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	83000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8642000	shares
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	393000000
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	14850000000
CY2012Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2446000000
CY2012Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1299000000
CY2012Q1	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	2600000000
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	105000000
CY2012Q1	us-gaap	Assets Current AssetsCurrent	50712000000
CY2012Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3700000000
CY2012Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5094000000
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8847000000
CY2012Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	110176000000
CY2012Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	278000000
CY2012Q1	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	43000000
CY2012Q1	aapl	Land And Buildings Gross LandAndBuildingsGross	2156000000
CY2012Q1	aapl	Off Balance Sheet Commitment Inventory Purchases OffBalanceSheetCommitmentInventoryPurchases	13000000000
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedTotalIntrinsicValue	10140707000
CY2012Q1	aapl	Machinery Equipment And Internal Use Software Gross MachineryEquipmentAndInternalUseSoftwareGross	8645000000
CY2012Q1	aapl	Operating Leases Future Minimum Payments Due Retail Space OperatingLeasesFutureMinimumPaymentsDueRetailSpace	2800000000
CY2012Q1	aapl	Notional Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	20505000000
CY2012Q1	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	336000000
CY2012Q1	aapl	Prepaid Expense Other Current Noncurrent PrepaidExpenseOtherCurrentNoncurrent	3300000000
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value At Period End ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestIntrinsicValueAtPeriodEnd	97150000
CY2012Q1	aapl	Collateral Already Received Aggregate Fair Value CollateralAlreadyReceivedAggregateFairValue	217000000
CY2012Q1	aapl	Number Of Countries NumberOfCountries	12	Country
CY2012Q1	aapl	Number Of Significant Vendors NumberOfSignificantVendors	2	Vendor
CY2012Q1	aapl	Long Term Marketable Securities Maturities Term Minimum LongTermMarketableSecuritiesMaturitiesTermMinimum	P1Y
CY2012Q1	aapl	Long Term Marketable Securities Maturities Term Maximum LongTermMarketableSecuritiesMaturitiesTermMaximum	P5Y
CY2012Q1	aapl	Major Facility Lease Terms Maximum Period MajorFacilityLeaseTermsMaximumPeriod	P10Y
CY2012Q1	aapl	Retail Lease Terms Majority Period RetailLeaseTermsMajorityPeriod	P10Y
CY2012Q1	aapl	Retail Lease Terms Maximum Period RetailLeaseTermsMaximumPeriod	P20Y
CY2012Q1	aapl	Retail Lease Terms Minimum Period RetailLeaseTermsMinimumPeriod	P5Y
CY2012Q1	aapl	Renewal Option Terms Maximum Additional Period RenewalOptionTermsMaximumAdditionalPeriod	P5Y
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedWeightedAverageExercisePrice	30.92
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice	128.57
CY2010Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	761000000
CY2010Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11261000000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1674000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1800000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	15701000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-119000000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1626000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	494000000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12163000000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10211000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	-296000000
	us-gaap	Share Based Compensation ShareBasedCompensation	586000000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	12.83
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1838000000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	502000000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30892000000
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	161000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15992000000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12251000000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	344000000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	698000000
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-183000000
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-539000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	728000000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4717000000
	us-gaap	Marketing Expense MarketingExpense	49000000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1886000000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	934549000	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	51408000000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	288000000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	90000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15863000000
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	236000000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.02
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1156000000
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	844000000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	976000000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	42260000000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	258000000
	us-gaap	Operating Expenses OperatingExpenses	4815000000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	921245000	shares
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-121000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13304000	shares
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1913000000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-12000000
	us-gaap	Gross Profit GrossProfit	20516000000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	21705000000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	81000000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	790000000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1563000000
	us-gaap	Net Income Loss NetIncomeLoss	11991000000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	162000000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	740000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3659000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	883000000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3872000000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-79000000
	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	2810000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	65.15
	dei	Trading Symbol TradingSymbol	AAPL
	dei	Entity Registrant Name EntityRegistrantName	APPLE INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-03-31
	dei	Entity Central Index Key EntityCentralIndexKey	0000320193
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-29
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	778000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1200000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	32724000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-208000000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2809000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	377000000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y22D
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	350000000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24767000000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	7702000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	6585000	shares
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	110000000
	us-gaap	Share Based Compensation ShareBasedCompensation	844000000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	26.17
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	102.91
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2778000000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	865000000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3243000	shares
	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46252000000
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.65
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-185000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31531000000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31604000000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-251000000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1916000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	3485000	shares
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	66000000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	85.54
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	384000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	306000000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1510000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	176.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	398.64
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y175D
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	943185000	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	85519000000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1663000000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33009000000
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	301000000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	26.48
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1599000000
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1303000000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	379000000
	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	10000000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	22000	shares
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	85022000000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	634000000
	us-gaap	Operating Expenses OperatingExpenses	6543000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	229.97
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	1400000000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	932265000	shares
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	326000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10920000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y44D
	us-gaap	Maximum Length Of Time Hedged In Cash Flow Hedge1 MaximumLengthOfTimeHedgedInCashFlowHedge1	P6M
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4835000000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	48000000
	us-gaap	Gross Profit GrossProfit	39267000000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	49052000000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	160000000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1461000000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2915000000
	us-gaap	Net Income Loss NetIncomeLoss	24686000000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	285000000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	636000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4944000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	379000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8323000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	632000	shares
CY2011Q1	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	1661000000
CY2011Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	68.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	400.79
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	263000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm	P4Y142D
	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	2459000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriod	41000	shares
	aapl	Range Of Time Hedged In Cash Flow Hedge RangeOfTimeHedgedInCashFlowHedge	The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases generally up to six months.
	aapl	Number Of Customers NumberOfCustomers	1	Customer
	aapl	Purchase Commitment Maximum Period Required PurchaseCommitmentMaximumPeriodRequired	P150D
	aapl	Schedule Of Derivative Instruments Effect On Income And Other Comprehensive Income ScheduleOfDerivativeInstrumentsEffectOnIncomeAndOtherComprehensiveIncome	<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table shows the pre-tax effect of the Company’s derivative instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2012 and March 26, 2011 (in millions):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr style="LINE-HEIGHT: 0pt; VISIBILITY: hidden; COLOR: white"> <td width="75%"></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="24" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Three Month Periods</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized in<br /> OCI - Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)  Reclassified</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>from AOCI into Income -<br /> Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="8" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized - Ineffective<br /> Portion and Amount Excluded from<br /> Effectiveness Testing</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 26,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012 (a)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 26,<br /> 2011 (b)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Location</b></font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 26,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cash flow hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(32</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(216</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">146</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(90</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Other income<br /> and expense</font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net investment hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(11</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Other income<br /> and expense</font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(32</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(227</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">146</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(90</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr style="LINE-HEIGHT: 0pt; VISIBILITY: hidden; COLOR: white"> <td width="76%"></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>September 30,</b></font></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="24" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Six Month Periods</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized in<br /> OCI - Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Reclassified</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>from AOCI into Income -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="8" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized - Ineffective</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Portion and Amount Excluded from</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effectiveness Testing</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 26,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012 (c)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 26,<br /> 2011 (d)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Location</b></font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 26,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cash flow hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">103</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(282</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">384</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(539</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">Other income<br /> and expense</font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(209</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(119</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net investment hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(14</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">Other income<br /> and expense</font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(296</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">384</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(539</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(208</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(119</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px">  </p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $154 million and $(8) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended March 31, 2012. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the three months ended March 31, 2012.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(24) million and $(66) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended March 26, 2011. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the three months ended March 26, 2011.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $341 million and $43 million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the six months ended March 31, 2012. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the six months ended March 31, 2012.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(281) million and $(258) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the six months ended March 26, 2011. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the six months ended March 26, 2011.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(e)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Refer to Note 5, “Shareholders’ Equity and Share-based Compensation” of this Form 10-Q, which summarizes the activity in AOCI related to derivatives.</font></p> </td> </tr> </table> </div>
CY2011Q1	us-gaap	Operating Expenses OperatingExpenses	2344000000
CY2011Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	923196000	shares
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	96.83
	aapl	Prepaid Expense And Other Current Noncurrent Utilized PrepaidExpenseAndOtherCurrentNoncurrentUtilized	593000000
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	875000000
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7874000000
CY2011Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-140000000
CY2011Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5999000000
CY2011Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	-227000000
CY2011Q1	us-gaap	Share Based Compensation ShareBasedCompensation	287000000
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.40
CY2011Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	249000000
CY2011Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14449000000
CY2011Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-82000000
CY2011Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	58000000
CY2011Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-140000000
CY2011Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-90000000
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	69000000
CY2011Q1	us-gaap	Marketing Expense MarketingExpense	25000000
CY2011Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	935944000	shares
CY2011Q1	us-gaap	Sales Revenue Net SalesRevenueNet	24667000000
CY2011Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	74000000
CY2011Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7900000000
CY2011Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	140000000
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.49
CY2011Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	581000000
CY2011Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	448000000
CY2011Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12748000	shares
CY2011Q1	us-gaap	Gross Profit GrossProfit	10218000000
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	5987000000
CY2011Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	26000000
CY2011Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1763000000
CY2011Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1913000000
CY2011Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	20000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	719000000
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15384000000
CY2012Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-140000000
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11762000000
CY2012Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	-32000000
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	424000000
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	12.30
CY2012Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	464000000
CY2012Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20622000000
CY2012Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-118000000
CY2012Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-97000000
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-21000000
CY2012Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	146000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	625000000
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	944893000	shares
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	39186000000
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9000000
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15532000000
CY2012Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	156000000
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	12.45
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	841000000
CY2012Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	466000000
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	3180000000
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	933582000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11311000	shares
CY2012Q1	us-gaap	Gross Profit GrossProfit	18564000000
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	11622000000
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	148000000
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2339000000
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3910000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	400.79
CY2012Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	249000000
CY2012Q1	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	1135000000
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriod	41000	shares
CY2012Q1	aapl	Number Of Customers NumberOfCustomers	1	Customer
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	105.25
CY2012Q1	aapl	Prepaid Expense And Other Current Noncurrent Utilized PrepaidExpenseAndOtherCurrentNoncurrentUtilized	542000000

Files In Submission

Name	View Source	Status
0001193125-12-182321-index-headers.html	Edgar Link	completed
0001193125-12-182321-index.html	Edgar Link	completed
0001193125-12-182321.txt	Edgar Link	completed
0001193125-12-182321-xbrl.zip	Edgar Link	completed
aapl-20120331.xml	Edgar Link	completed
aapl-20120331.xsd	Edgar Link	completed
aapl-20120331_cal.xml	Edgar Link	unprocessable
aapl-20120331_def.xml	Edgar Link	unprocessable
aapl-20120331_lab.xml	Edgar Link	unprocessable
aapl-20120331_pre.xml	Edgar Link	unprocessable
d297069d10q.htm	Edgar Link	completed
d297069dex108.htm	Edgar Link	completed
d297069dex141.htm	Edgar Link	completed
d297069dex311.htm	Edgar Link	completed
d297069dex312.htm	Edgar Link	completed
d297069dex321.htm	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	completed
g297069g27q68.jpg	Edgar Link	completed
R1.htm	Edgar Link	completed
R10.htm	Edgar Link	completed
R11.htm	Edgar Link	completed
R12.htm	Edgar Link	completed
R13.htm	Edgar Link	completed
R14.htm	Edgar Link	completed
R15.htm	Edgar Link	completed
R16.htm	Edgar Link	completed
R17.htm	Edgar Link	completed
R18.htm	Edgar Link	completed
R19.htm	Edgar Link	completed
R2.htm	Edgar Link	completed
R20.htm	Edgar Link	completed
R21.htm	Edgar Link	completed
R22.htm	Edgar Link	completed
R23.htm	Edgar Link	completed
R24.htm	Edgar Link	completed
R25.htm	Edgar Link	completed
R26.htm	Edgar Link	completed
R27.htm	Edgar Link	completed
R28.htm	Edgar Link	completed
R29.htm	Edgar Link	completed
R3.htm	Edgar Link	completed
R30.htm	Edgar Link	completed
R31.htm	Edgar Link	completed
R32.htm	Edgar Link	completed
R33.htm	Edgar Link	completed
R34.htm	Edgar Link	completed
R35.htm	Edgar Link	completed
R36.htm	Edgar Link	completed
R37.htm	Edgar Link	completed
R38.htm	Edgar Link	completed
R39.htm	Edgar Link	completed
R4.htm	Edgar Link	completed
R40.htm	Edgar Link	completed
R41.htm	Edgar Link	completed
R42.htm	Edgar Link	completed
R5.htm	Edgar Link	completed
R6.htm	Edgar Link	completed
R7.htm	Edgar Link	completed
R8.htm	Edgar Link	completed
R9.htm	Edgar Link	completed
report.css	Edgar Link	completed
Show.js	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAPL
Apple Inc. Stock $aapl

2012 Q1 Form 10-Q Financial Statement

#000119312512182321 Filed on April 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAPL Apple Inc. Stock $aapl

2012 Q1 Form 10-Q Financial Statement

#000119312512182321 Filed on April 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAPL
Apple Inc. Stock $aapl